Connect with us

Cannabis News

Medical Marijuana Inc’s HempMeds Set To Launch CBD Pet Product Line At SuperZoo 2019





Medical Marijuana, Inc. – the company behind the world’s first cannabis-derived nutraceutical products – has announced that its subsidiary HempMeds® will attend and exhibit its products at SuperZoo, North America’s most attended pet industry show, in Las Vegas from August 20 to 22.

HempMeds® will use this platform to unveil its new line of CBD pet products – Hemp For Pets – made with the company’s triple-lab tested full-spectrum hemp, and THC-free isolate oil.

Recently, the Brightfield Group reported that the United States market for pet products was worth $32 million last year and is expected to hit $1.16 billion by 2022.

According to the President of HempMeds®, HempMeds was developed to offer the most powerful and quality hemp that can make a difference in the lives of pets.

SuperZoo was formed in 1950 by the World Pet Association as an annual gathering platform for the pet industry players to connect, learn, and transact. The show has continually grown over the last 69 years and now boasts more education hours and buyers than any other industry event all over the world. With its easy-to-shop show floor and diverse education offerings, SuperZoo has earned a name as the premier pet retail event in North America. In 2018, SuperZoo hosted about 1,200 exhibitors and 10,000 attendees.

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Join Us On Facebook


Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?